Have You Been Harmed By One Of The Drugs Or Other Medical Products Covered On This Site?

If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!

First Name:

Last Name:

Street Address:

City:

State:

Zip:

Daytime Phone Number:

Alternate Phone Number (Optional):

E-Mail Address:



Is this request for you or someone else?
Myself
My Spouse or
Minor Child
Other Relative or Friend

Drug Or Device Exposed To:


Dates Taken:


Related Health Problems Caused By The Drug:


Vioxx Heart Attacks Could Occur In First Couple Of Weeks

Added May 22nd, 2006

A new study has concluded that the controversial cox 2 inhibitor drug Vioxx could cause heart attacks within the first couple of weeks of use. Vioxx is a painkilling anti-inflammatory drug that has been at the center of much controversy and many lawsuits after it was discovered that the side effects of the drug could and have been serious and even fatal.

The latest study was carried out at Queen’s University. One of the researchers on the project stated that around 25% of Vioxx users who suffered heart attacks did so within a couple of weeks of starting the drug treatment. She stated: "This demonstrates that cardiovascular risks from taking Vioxx may occur much earlier than previously believed."

The Canadian Medical Association Journal recently published the findings of the study. One of the researchers on the project added: "Our previous study on COX-2 inhibitors, which included Vioxx and Celebrex, evaluated whether there was an increased risk of heart attack while taking these medications; the answer was yes for Vioxx."

In the study the pattern relating to risk of heart attacks was assessed over a three year period. The study concluded that the risk actually decreased with time, and that those at highest risk were new users of the drug.

Vioxx Heart Attacks... | Printable Version (Opens In New Window)


Important Notice: RYAR.org is a legal informational site sponsored by the Peterson Firm, LLC. The Peterson Firm’s office is located at: 20 N. Orange Ave - Suite 400, Orlando, Florida 32801. The Peterson Firm is licensed by the Florida Bar Association to practice law within the state of Florida. If the Peterson Firm undertakes representation of a client outside the state of Florida, it will do so with assistance of local counsel from a law firm located in the state where the case is filed. If Peterson Firm undertakes representation in the state of Florida it will also do so with assistance of co counsel.

The content contained herein was not prepared by lawyers and should not be taken as a substitute for legal advice from a licensed attorney. Additionally, this information is not intended to create an attorney-client relationship simply by its viewing. The creation of an attorney-client relationship requires more than viewing this or affiliated websites. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may or may not be applicable to a viewer’s individual legal needs. Online readers should not act on this information without seeking professional counsel. Please read our 'Terms & Conditions Of Use' for more information.

Additionally, the information contained on RYAR.org, including but not limited to informational articles, other text/images, and on or off site links, has not been prepared, endorsed, or reviewed by any form of licensed medical professional, including but not limited to physicians, doctors, and so on. Nothing on the this website should be taken as medical advice, but instead should act as a useful resource in providing general information that may be useful to members of the general public. All visitors are encouraged to consult with a physician or other licensed medical professional for any form of medical advice. Please see our 'Terms & Conditions Of Use' for further information